You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 10, October 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  REVIEWS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Molecular Basis of Nonmelanoma Skin Cancer

New Understanding

Douglas Grossman, MD, PhD; David J. Leffell, MD

Arch Dermatol. 1997;133(10):1263-1270.


Abstract

Nonmelanoma skin cancers, including basal cell carcinomas and squamous cell carcinomas, represent the most common malignant neoplasms in humans. Although many environmental and genetic factors contribute to the development of skin cancers, the most important is chronic exposure to UV radiation in sunlight. We now appreciate that the role of UV in the development of nonmelanoma skin cancers is 2-fold. First, UV radiation causes mutations in cellular DNA. Failure to repair these genetic alterations ultimately leads to unrestrained growth and tumor formation. Second, UV radiation has profound effects on the cutaneous immune system, inducing a state of relative immunosuppression that prevents tumor rejection. The purpose of this review is to educate clinical dermatologists about the recent developments in molecular biology and immunology that have greatly enhanced our understanding of how skin cancers arise. The clinical implications of this new knowledge are farreaching and likely to soon impact the diagnosis, treatment, and prevention of a variety of benign and malignant skin conditions. It will be important for the clinician to understand the biological mechanisms underlying these new therapeutic developments to implement them effectively.

Arch Dermatol. 1997;133:1263-1270



Author Affiliations

From the Departments of Dermatology (Drs Grossman and Leffell) and Surgery (Dr Leffell), Yale University School of Medicine, New Haven, Conn.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chemoprevention of Human Actinic Keratoses by Topical DL-{alpha}-tocopherol
Foote et al.
Cancer Prevention Research 2009;2:394-400.
ABSTRACT | FULL TEXT  

T-oligos augment UV-induced protective responses in human skin
Arad et al.
FASEB J. 2006;20:1895-1897.
ABSTRACT | FULL TEXT  

Role of Dietary Factors in the Development of Basal Cell Cancer and Squamous Cell Cancer of the Skin
McNaughton et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:1596-1607.
ABSTRACT | FULL TEXT  

UVB-induced apoptosis drives clonal expansion during skin tumor development
Zhang et al.
Carcinogenesis 2005;26:249-257.
ABSTRACT | FULL TEXT  

XPD Polymorphism and Risk of Subsequent Cancer in Individuals with Nonmelanoma Skin Cancer
Brewster et al.
Cancer Epidemiol. Biomarkers Prev. 2004;13:1271-1275.
ABSTRACT | FULL TEXT  

The Prevalence of Human Papillomavirus Genotypes in Nonmelanoma Skin Cancers of Nonimmunosuppressed Individuals Identifies High-Risk Genital Types as Possible Risk Factors
Iftner et al.
Cancer Res. 2003;63:7515-7519.
ABSTRACT | FULL TEXT  

Cutaneous Squamous-Cell Carcinoma
Alam and Ratner
NEJM 2001;344:975-983.
FULL TEXT  

Increase of Oxidatively Modified Protein Is Associated With a Decrease of Proteasome Activity and Content in Aging Epidermal Cells
Petropoulos et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2000;55:220B-227.
ABSTRACT | FULL TEXT  

Prevention of Nonmelanoma Skin Cancer
Baron and Greenberg
Arch Dermatol 2000;136:245-246.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.